Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-8-17
pubmed:abstractText
Hepatitis C virus (HCV) infections are treated with interferon alpha plus ribavirin, but it is unknown how ribavirin works against HCV. Ribavirin is a guanosine analogue that can be a substrate for the viral RNA polymerase. HCV is genetically variable, and this genetic variation could affect the polymerase's use of ribavirin triphosphate. Thirteen patients infected with HCV who failed interferon alpha monotherapy and were retreated with interferon alpha plus ribavirin were identified; seven were responders and six were nonresponders to combination therapy. The consensus sequences encoding the 13 polymerases plus seven sequences from treatment-naive controls were determined. The responder sequences were more genetically variable than the nonresponders and controls, the amino acid variations unique to responders had lower BLOSUM90 scores than variations in nonresponders and controls, and the amino acid variations correlated with response to therapy clustered around the RNA-binding channel of the polymerase. These data imply that that the responder enzymes were probably more functionally variable than the nonresponder enzymes. Enzymatic activity was measured for 10 recombinant polymerases; RNA synthesis activity varied by over sevenfold and polymerases from two of the responders used GTP much better than UTP, but technical limitations prevented direct measurement of ribavirin triphosphate use. Because response to combination therapy in these patients was primarily due to addition of ribavirin to the treatment regimen, these data imply that genetic variation in the polymerase may have affected the efficiency of ribavirin incorporation into the viral genome and hence may have modulated ribavirin's efficacy against HCV.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-10047577, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-10322129, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-10364165, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-10438811, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-10557268, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-10869301, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-11230751, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-11371613, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-11483752, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-11583749, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-11677216, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-11884572, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-12022223, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-12127780, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-12324553, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-12509436, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-12930968, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-12950173, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-14512874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-14760887, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-14988824, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-15602565, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-15939449, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-16126720, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-16321149, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-17484873, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-17484896, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-18463735, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-2626057, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-280136, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-7597443, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-8245854, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-9807989, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-9819446, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-9882374, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243495-9930205
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1365-2893
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
595-604
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Evidence for action of ribavirin through the hepatitis C virus RNA polymerase.
pubmed:affiliation
Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St Louis, MO 63104, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural